Xiuzheng Pharmaceutical Group Co., Ltd.
Xiuzheng Group was founded by Chairman Xiu Laigui in May 1995. It is a large modern private pharmaceutical enterprise integrating scientific research, production and marketing of patent medicines, chemical medicines, and biopharmaceuticals, pharmaceutical chain operations, and standard cultivation of traditional Chinese medicinal materials. Through secondary development, the group has cultivated more than a dozen major varieties such as Feining, Empty Hydrochloride, Liuwei Dihuang, Neiyaku Kang, Yiqi and Blood Health, etc.; it has integrated the transformation of scientific and technological management, innovative drug research, and new technological achievements into a domestic one. The scientific research system has more than 300 technical experts, more than 700 authorized patents, and won 7 national scientific and technological progress awards. There are nationally certified enterprise technology centers, national engineering laboratories for quality control technology in traditional Chinese medicine, postdoctoral research workstations, and key laboratories for key engineering technology in traditional Chinese medicine standardization. Correcting health is an important support for the big health strategy and an important wing for the revision of the "professional development, two wings flying together" strategy. Starting from 2021, we will focus on health product research and development and health management. Headquarters are located in Changchun, Jilin and Hangzhou, Zhejiang, respectively, including 8 industrial bases, covering an area of more than 1,000 mu. Currently, six industrial bases in Changchun Shuangyang, Jilin Panshi, Baishan Jingyu, Shandong Weifang, Anhui Bozhou and Hangzhou Qiandaohu have been put into production. , sales channels cover multiple channels such as e-commerce, new retail, maternal and infant, pharmacies and supermarket third terminals. Currently, there are about 670 varieties in production and sales, 404 registered trademarks, and 50 patents. Its well-known products such as Spot Cream, Red Bean and Barley Tea, Xiuyisheng Probiotics, Uer Capsules, Svino Oral Liquid, Glycosammonia Chondroitin, and Youzhi DHA are well-known throughout the country, occupying the leading position in the big health sector and are deeply influenced by Good reviews from consumers. The product line covers a variety of dosage forms such as health foods, nourishing foods, fast-selling foods, alternative teas, health wines, mineral water, functional cosmetics, cosmetics, etc.
Xiuzheng Pharmaceutical Group Co., Ltd.
Xiuzheng Group was founded by Chairman Xiu Laigui in May 1995. It is a large modern private pharmaceutical enterprise integrating scientific research, production and marketing of patent medicines, chemical medicines, and biopharmaceuticals, pharmaceutical chain operations, and standard cultivation of traditional Chinese medicinal materials. Through secondary development, the group has cultivated more than a dozen major varieties such as Feining, Empty Hydrochloride, Liuwei Dihuang, Neiyaku Kang, Yiqi and Blood Health, etc.; it has integrated the transformation of scientific and technological management, innovative drug research, and new technological achievements into a domestic one. The scientific research system has more than 300 technical experts, more than 700 authorized patents, and won 7 national scientific and technological progress awards. There are nationally certified enterprise technology centers, national engineering laboratories for quality control technology in traditional Chinese medicine, postdoctoral research workstations, and key laboratories for key engineering technology in traditional Chinese medicine standardization. Correcting health is an important support for the big health strategy and an important wing for the revision of the "professional development, two wings flying together" strategy. Starting from 2021, we will focus on health product research and development and health management. Headquarters are located in Changchun, Jilin and Hangzhou, Zhejiang, respectively, including 8 industrial bases, covering an area of more than 1,000 mu. Currently, six industrial bases in Changchun Shuangyang, Jilin Panshi, Baishan Jingyu, Shandong Weifang, Anhui Bozhou and Hangzhou Qiandaohu have been put into production. , sales channels cover multiple channels such as e-commerce, new retail, maternal and infant, pharmacies and supermarket third terminals. Currently, there are about 670 varieties in production and sales, 404 registered trademarks, and 50 patents. Its well-known products such as Spot Cream, Red Bean and Barley Tea, Xiuyisheng Probiotics, Uer Capsules, Svino Oral Liquid, Glycosammonia Chondroitin, and Youzhi DHA are well-known throughout the country, occupying the leading position in the big health sector and are deeply influenced by Good reviews from consumers. The product line covers a variety of dosage forms such as health foods, nourishing foods, fast-selling foods, alternative teas, health wines, mineral water, functional cosmetics, cosmetics, etc.
Renhe (Group) Development Co., Ltd.
Renhe Pharmaceutical Co., Ltd. is a listed company listed on the Shenzhen Stock Exchange. The company's stock code is: 000650. The company's predecessor is Jiujiang Chemical Fiber Co., Ltd., which was approved by the Jiangxi Provincial People's Government in 1996. On November 18, 1996 , a company officially listed on the Shenzhen Stock Exchange with the approval of the China Securities Regulatory Commission’s Securities Regulatory Commission (1996) No. 318. In 2006, the company implemented a major asset restructuring, divested its original chemical fiber-related assets, and injected pharmaceutical assets. Through multiple share allocations, transfers, targeted share issuances, etc., the company has become Jiangxi Renhe Pharmaceutical Co., Ltd. and Jiangxi Renhe. China Pharmaceutical Co., Ltd., Jiangxi Renhe Pharmaceutical Co., Ltd., Jiangxi Heli Pharmaceutical Co., Ltd., Jiangxi Kangmei Pharmaceutical Health Products Co., Ltd., Jiangxi Pharmaceutical Durenhe Pharmaceutical Co., Ltd., Jiangxi Tonggu Renhe Pharmaceutical Co., Ltd., Jiangxi Shining Pharmaceutical Modern pharmaceutical production and operation enterprises of many subsidiaries such as Jiangxi Ji'an Sanli Pharmaceutical Co., Ltd., Jiangxi Renhe Pharmaceutical Products Co., Ltd., Jiangxi Pharmaceutical Co., Ltd., Jiangxi Pharmaceutical Co., Ltd., Jiangxi Pharmaceutical City Zhangshu Pharmaceutical Co., Ltd. and other subsidiaries. The company's main business: production and sales of traditional Chinese and Western medicines, raw materials and health-related products, including oral solid preparations, oral liquid preparations, large-volume injections, small-volume injections, topical lotions, liniments, suppositories, ointments and other dosage-form drugs, as well as Health-related products. The company's main products: Renhe Kelik, Youkadan series, Fuyanjie series, Dahuolou capsules, Shining eye drops, Qinghuo capsules, Zhengwei capsules, etc. Business scope is: Chinese medicinal materials planting; medicinal seedling cultivation; carton production and sales; computer software development; design, production, release, and agency of various domestic advertisements; building materials, machinery and equipment, hardware and electrical and electronic products, chemical products, Wholesale and retail of metal materials, cultural and sports office supplies, department stores. (Except for the above projects that have special provisions in the country). The company has established and consolidated a sales network covering 30 provinces, cities and autonomous regions across the country. The company adheres to the purpose of "serving human health", follows the corporate philosophy of "people-oriented and harmony-oriented", and the business philosophy of "benevolence and harmony, and win-win" and promotes the corporate spirit of "integrity and unity and keeping pace with the times". With the historical expectation of revitalizing the country's medical industry, we will go to the world and the future with new horizons and new ideas.
Renhe (Group) Development Co., Ltd.
Renhe Pharmaceutical Co., Ltd. is a listed company listed on the Shenzhen Stock Exchange. The company's stock code is: 000650. The company's predecessor is Jiujiang Chemical Fiber Co., Ltd., which was approved by the Jiangxi Provincial People's Government in 1996. On November 18, 1996 , a company officially listed on the Shenzhen Stock Exchange with the approval of the China Securities Regulatory Commission’s Securities Regulatory Commission (1996) No. 318. In 2006, the company implemented a major asset restructuring, divested its original chemical fiber-related assets, and injected pharmaceutical assets. Through multiple share allocations, transfers, targeted share issuances, etc., the company has become Jiangxi Renhe Pharmaceutical Co., Ltd. and Jiangxi Renhe. China Pharmaceutical Co., Ltd., Jiangxi Renhe Pharmaceutical Co., Ltd., Jiangxi Heli Pharmaceutical Co., Ltd., Jiangxi Kangmei Pharmaceutical Health Products Co., Ltd., Jiangxi Pharmaceutical Durenhe Pharmaceutical Co., Ltd., Jiangxi Tonggu Renhe Pharmaceutical Co., Ltd., Jiangxi Shining Pharmaceutical Modern pharmaceutical production and operation enterprises of many subsidiaries such as Jiangxi Ji'an Sanli Pharmaceutical Co., Ltd., Jiangxi Renhe Pharmaceutical Products Co., Ltd., Jiangxi Pharmaceutical Co., Ltd., Jiangxi Pharmaceutical Co., Ltd., Jiangxi Pharmaceutical City Zhangshu Pharmaceutical Co., Ltd. and other subsidiaries. The company's main business: production and sales of traditional Chinese and Western medicines, raw materials and health-related products, including oral solid preparations, oral liquid preparations, large-volume injections, small-volume injections, topical lotions, liniments, suppositories, ointments and other dosage-form drugs, as well as Health-related products. The company's main products: Renhe Kelik, Youkadan series, Fuyanjie series, Dahuolou capsules, Shining eye drops, Qinghuo capsules, Zhengwei capsules, etc. Business scope is: Chinese medicinal materials planting; medicinal seedling cultivation; carton production and sales; computer software development; design, production, release, and agency of various domestic advertisements; building materials, machinery and equipment, hardware and electrical and electronic products, chemical products, Wholesale and retail of metal materials, cultural and sports office supplies, department stores. (Except for the above projects that have special provisions in the country). The company has established and consolidated a sales network covering 30 provinces, cities and autonomous regions across the country. The company adheres to the purpose of "serving human health", follows the corporate philosophy of "people-oriented and harmony-oriented", and the business philosophy of "benevolence and harmony, and win-win" and promotes the corporate spirit of "integrity and unity and keeping pace with the times". With the historical expectation of revitalizing the country's medical industry, we will go to the world and the future with new horizons and new ideas.
Guilong Pharmaceutical (Anhui) Co., Ltd.
In 1989, Guilong Pharmaceutical carried the huge waves of the traditional Eastern culture of thousands of years. "Guilong" symbolizes the green osmanthus trees in all seasons. The fragrance spreads thousands of miles and is simple and elegant. It is the embodiment of traditional Chinese medicine; "Dragon" symbolizes the East. Culture and the power to build momentum. Since its establishment, the company has been aiming to "inherit the essence of Chinese medicine and be healthy for the people" and continue to research and innovate scientific research. The Slow Yan Shuning brand under Guilong Pharmaceutical is one of the innovative brands that inherits the classic prescriptions of court medical cases in the Qing Dynasty and creates "China's leading brand of throat health". Good products are the foundation of a company's life, and conscientious medicine is the source of trust in the people. A good reputation and corporate brand image are achieved through their own product strength. Slow Yan Shuning, focusing on the field of throat health, has established a good corporate image in the industry and consumers' minds with the significant efficacy and safety performance of the products. It has been on the Healthy China Brand List for many years and has become a model of drug safety. The reason why Yan Shuning achieved such brilliant achievements is inseparable from her own continuous research and development and innovation and continuous excellence. Based on R&D, the company aims to be a professional throat health brand in China and a brand responsible for consumers' health. Brand strategy is an important part of Guilong's soft power. Guilong’s management believes that “the success of a company is ultimately reflected in the success of the brand.” This is what the Guilong people think and do the same. Slow Yan Shuning’s professional brand and quality have brought good news to the people’s throat health, but it has not slacked off and stopped here. Instead, it has always adhered to concept innovation, management innovation, technological innovation, and job innovation, and conducted in-depth research on the needs of patients with throat disease. , constantly launch new products to meet the different needs of throat problems from light to severe, and comprehensively solve throat problems. It has products such as Qingluo Liyu Granules, Haoshuang Soft Soft Soft Soft Soft Soft Soft Soft Soft Soft Soft Soft Soft Soft Soft Soft Soft Soft Soft Soft Soft Soft Soft Soft Soft Soft Soft Soft Soft Soft Soft Soft Soft Soft Soft Soft Soft Soft Soft Soft Soft Soft Soft Soft Soft Soft Soft Soft Soft Soft Soft Soft Soft Soft Soft The granules were rated as "a key category of over-the-counter drugs in China" by the China Over-the-counter Drug Association.
Guilong Pharmaceutical (Anhui) Co., Ltd.
In 1989, Guilong Pharmaceutical carried the huge waves of the traditional Eastern culture of thousands of years. "Guilong" symbolizes the green osmanthus trees in all seasons. The fragrance spreads thousands of miles and is simple and elegant. It is the embodiment of traditional Chinese medicine; "Dragon" symbolizes the East. Culture and the power to build momentum. Since its establishment, the company has been aiming to "inherit the essence of Chinese medicine and be healthy for the people" and continue to research and innovate scientific research. The Slow Yan Shuning brand under Guilong Pharmaceutical is one of the innovative brands that inherits the classic prescriptions of court medical cases in the Qing Dynasty and creates "China's leading brand of throat health". Good products are the foundation of a company's life, and conscientious medicine is the source of trust in the people. A good reputation and corporate brand image are achieved through their own product strength. Slow Yan Shuning, focusing on the field of throat health, has established a good corporate image in the industry and consumers' minds with the significant efficacy and safety performance of the products. It has been on the Healthy China Brand List for many years and has become a model of drug safety. The reason why Yan Shuning achieved such brilliant achievements is inseparable from her own continuous research and development and innovation and continuous excellence. Based on R&D, the company aims to be a professional throat health brand in China and a brand responsible for consumers' health. Brand strategy is an important part of Guilong's soft power. Guilong’s management believes that “the success of a company is ultimately reflected in the success of the brand.” This is what the Guilong people think and do the same. Slow Yan Shuning’s professional brand and quality have brought good news to the people’s throat health, but it has not slacked off and stopped here. Instead, it has always adhered to concept innovation, management innovation, technological innovation, and job innovation, and conducted in-depth research on the needs of patients with throat disease. , constantly launch new products to meet the different needs of throat problems from light to severe, and comprehensively solve throat problems. It has products such as Qingluo Liyu Granules, Haoshuang Soft Soft Soft Soft Soft Soft Soft Soft Soft Soft Soft Soft Soft Soft Soft Soft Soft Soft Soft Soft Soft Soft Soft Soft Soft Soft Soft Soft Soft Soft Soft Soft Soft Soft Soft Soft Soft Soft Soft Soft Soft Soft Soft Soft Soft Soft Soft Soft Soft Soft Soft Soft Soft Soft Soft The granules were rated as "a key category of over-the-counter drugs in China" by the China Over-the-counter Drug Association.
China Resources Pharmaceutical Holdings Co., Ltd.
China Resources Sanjiu Pharmaceutical Co., Ltd. (hereinafter referred to as "China Resources Sanjiu") is a large state-owned pharmaceutical listed company, mainly engaged in the research and development, production, sales and related health services of pharmaceutical products. Up to now, China Resources Sanjiu has been included in the Shenzhen Component Index, CSI 500 and FTSE Russell Index. China Resources Sanjiu was predecessored by Shenzhen Southern Pharmaceutical Factory established in 1985. In 1999, five companies including Sanjiu Enterprise Group and Shenzhen Sanjiu Pharmaceutical Co., Ltd. initiated the establishment of joint-stock companies; on March 9, 2000, it was listed on the Shenzhen Stock Exchange (stock code is 000999); in 2008, Officially entered China Resources Group; in 2010, the company's name was changed from "Sanjiu Pharmaceutical Co., Ltd." to "China Resources Sanjiu Pharmaceutical Co., Ltd.". China Resources Sanjiu’s main core business is positioned in the fields of CHC health consumer goods and prescription drugs, with a rich product line and a continuous enrichment of varieties. CHC's health consumer products business covers nearly 10 categories including colds, skin, gastrointestinal tract, cough relieving, orthopedics, pediatrics, dietary nutritional supplements, and its core products occupy a high market share; prescription drug business covers cardiovascular, anti-tumor, Digestive system, orthopedics, pediatrics, anti-infection and other treatment fields, it has the Xuesaitong Panax notoginseng series products, Shenfu injection, mitoxantrone hydrochloride injection for tracer, Huachansu tablets and injections, Yixuesheng Capsule , blood stasis, and sodium cefbiroster for injection have a high reputation in the medical end. In 2023, China Resources Sanjiu has 39 varieties with annual sales of over 100 million yuan, including "999 Cold Ling", "999 Dermatitis Ping", "Sanjiu Weitai", "999 Children's Cold Granules", and "999 Antiviral Oral Liquid ", "Qizhiwei Puer Granules", "Tianhe Gutong Tie Paste", "Yi Shanfu", "999 Aonuo Calcium Gluconate Zinc Oral Solution", "Xuesaitong Panax noto Series Products", "Kun Chinese Medicine Ginseng Lingjianpiwei Granules", "Afacalciferol Soft Capsules", "Sodium Hyaluronic Acid Injection" and so on have a leading position in related categories. The "999" brand enjoys high recognition in both the consumer and pharmaceutical industries. China Resources Sanjiu has always attached great importance to R&D and innovation. During the "14th Five-Year Plan" strategic period, China Resources Sanjiu will focus on the strategic direction, continue to increase R&D investment, improve the construction of innovation systems and mechanisms, and enhance innovation and development capabilities. While increasing the cooperation between industry, academia and research, three research institutes of innovative drugs, traditional Chinese medicine and health drugs have been established and operated one after another; innovative cooperation with Shenzhen Bay Laboratory has been carried out in depth, and clinical related to the QBH-196 project of anti-tumor innovative drug QBH-196 project has been vigorously promoted. Research. In 2023, R&D investment was 889 million yuan, and the proportion of new product R&D investment increased. There are a total of 112 projects under development, mainly focusing on anti-tumor, orthopedics, skin, respiratory, anti-infection and other treatment fields, and in new product project establishment, product R&D, and product strength. Positive progress has been made in areas such as improvement. China Resources Sanjiu attaches great importance to the inheritance and innovation of traditional Chinese medicine, continues to deepen the full-process development system of traditional Chinese medicine, precipitates the research and development capabilities of traditional Chinese medicine, and focuses on the research on classic prescriptions of traditional Chinese medicine, standards of traditional Chinese medicine formula granules and medicinal materials resources. The classic prescription embodies the essence of traditional Chinese medicine. The company adheres to the research idea of "inheriting the essence, keeping the truth and innovation", focuses on the elderly, women, and children, covering the treatment fields of breathing, heart and brain, digestion, etc., and carries out "Medicinal Materials-Decoction-Benchmark Sample- Systematic research on compound preparations, and build a traceability system for the entire industrial chain of traditional Chinese medicine. China Resources Sanjiu continues to pay attention to high-quality domestic and foreign resources, and makes strategic mergers and acquisitions integration efforts. Among them, China Resources Sanjiu and its holding subsidiary Kunzi Pharmaceutical Group have good synergy in terms of brands, products, channels, etc., and the business integration is progressing smoothly. We empower each other in the development of the Panax notoginseng industry and the creation of the "Kunzi Chinese Medicine 1381" brand. Coordinated development will promote Kunming Pharmaceutical Group to become the first healthy stock in silver economics. Against the backdrop of the ever-changing environment of the pharmaceutical industry, China Resources Sanjiu embraces industry and market development opportunities, leads "high-quality development" with innovation, adheres to the dual-wheel drive of "brand + innovation", and focuses on innovation and research and development of high-quality pharmaceutical and health products and intelligent manufacturing , optimize business layout, strengthen brand and channel construction, increase innovation investment, actively explore innovative development models of industrial chains, build competitive advantages of the entire industrial chain of traditional Chinese medicine, improve operational quality and efficiency, and achieve steady improvement in operating performance and core capabilities. During the "14th Five-Year Plan" strategic period, China Resources Sanjiu made solid progress on the road to becoming a leading enterprise in the industry, benchmarking against world-class enterprises, improving business layout, expanding its core business into the entire field of self-diagnosis and treatment, developing business focus on pipelines, and as the core Business empowerment to form a business model with "deep roots and lush leaves". Looking to the future, China Resources Sanjiu will always keep in mind its original mission and work hard to work hard. Under the mission of "caring for public health and creating a better life together", we will forge ahead to the goal of "leader of the mass medical and health industry" and serve Every member of the Chinese family.
China Resources Pharmaceutical Holdings Co., Ltd.
China Resources Sanjiu Pharmaceutical Co., Ltd. (hereinafter referred to as "China Resources Sanjiu") is a large state-owned pharmaceutical listed company, mainly engaged in the research and development, production, sales and related health services of pharmaceutical products. Up to now, China Resources Sanjiu has been included in the Shenzhen Component Index, CSI 500 and FTSE Russell Index. China Resources Sanjiu was predecessored by Shenzhen Southern Pharmaceutical Factory established in 1985. In 1999, five companies including Sanjiu Enterprise Group and Shenzhen Sanjiu Pharmaceutical Co., Ltd. initiated the establishment of joint-stock companies; on March 9, 2000, it was listed on the Shenzhen Stock Exchange (stock code is 000999); in 2008, Officially entered China Resources Group; in 2010, the company's name was changed from "Sanjiu Pharmaceutical Co., Ltd." to "China Resources Sanjiu Pharmaceutical Co., Ltd.". China Resources Sanjiu’s main core business is positioned in the fields of CHC health consumer goods and prescription drugs, with a rich product line and a continuous enrichment of varieties. CHC's health consumer products business covers nearly 10 categories including colds, skin, gastrointestinal tract, cough relieving, orthopedics, pediatrics, dietary nutritional supplements, and its core products occupy a high market share; prescription drug business covers cardiovascular, anti-tumor, Digestive system, orthopedics, pediatrics, anti-infection and other treatment fields, it has the Xuesaitong Panax notoginseng series products, Shenfu injection, mitoxantrone hydrochloride injection for tracer, Huachansu tablets and injections, Yixuesheng Capsule , blood stasis, and sodium cefbiroster for injection have a high reputation in the medical end. In 2023, China Resources Sanjiu has 39 varieties with annual sales of over 100 million yuan, including "999 Cold Ling", "999 Dermatitis Ping", "Sanjiu Weitai", "999 Children's Cold Granules", and "999 Antiviral Oral Liquid ", "Qizhiwei Puer Granules", "Tianhe Gutong Tie Paste", "Yi Shanfu", "999 Aonuo Calcium Gluconate Zinc Oral Solution", "Xuesaitong Panax noto Series Products", "Kun Chinese Medicine Ginseng Lingjianpiwei Granules", "Afacalciferol Soft Capsules", "Sodium Hyaluronic Acid Injection" and so on have a leading position in related categories. The "999" brand enjoys high recognition in both the consumer and pharmaceutical industries. China Resources Sanjiu has always attached great importance to R&D and innovation. During the "14th Five-Year Plan" strategic period, China Resources Sanjiu will focus on the strategic direction, continue to increase R&D investment, improve the construction of innovation systems and mechanisms, and enhance innovation and development capabilities. While increasing the cooperation between industry, academia and research, three research institutes of innovative drugs, traditional Chinese medicine and health drugs have been established and operated one after another; innovative cooperation with Shenzhen Bay Laboratory has been carried out in depth, and clinical related to the QBH-196 project of anti-tumor innovative drug QBH-196 project has been vigorously promoted. Research. In 2023, R&D investment was 889 million yuan, and the proportion of new product R&D investment increased. There are a total of 112 projects under development, mainly focusing on anti-tumor, orthopedics, skin, respiratory, anti-infection and other treatment fields, and in new product project establishment, product R&D, and product strength. Positive progress has been made in areas such as improvement. China Resources Sanjiu attaches great importance to the inheritance and innovation of traditional Chinese medicine, continues to deepen the full-process development system of traditional Chinese medicine, precipitates the research and development capabilities of traditional Chinese medicine, and focuses on the research on classic prescriptions of traditional Chinese medicine, standards of traditional Chinese medicine formula granules and medicinal materials resources. The classic prescription embodies the essence of traditional Chinese medicine. The company adheres to the research idea of "inheriting the essence, keeping the truth and innovation", focuses on the elderly, women, and children, covering the treatment fields of breathing, heart and brain, digestion, etc., and carries out "Medicinal Materials-Decoction-Benchmark Sample- Systematic research on compound preparations, and build a traceability system for the entire industrial chain of traditional Chinese medicine. China Resources Sanjiu continues to pay attention to high-quality domestic and foreign resources, and makes strategic mergers and acquisitions integration efforts. Among them, China Resources Sanjiu and its holding subsidiary Kunzi Pharmaceutical Group have good synergy in terms of brands, products, channels, etc., and the business integration is progressing smoothly. We empower each other in the development of the Panax notoginseng industry and the creation of the "Kunzi Chinese Medicine 1381" brand. Coordinated development will promote Kunming Pharmaceutical Group to become the first healthy stock in silver economics. Against the backdrop of the ever-changing environment of the pharmaceutical industry, China Resources Sanjiu embraces industry and market development opportunities, leads "high-quality development" with innovation, adheres to the dual-wheel drive of "brand + innovation", and focuses on innovation and research and development of high-quality pharmaceutical and health products and intelligent manufacturing , optimize business layout, strengthen brand and channel construction, increase innovation investment, actively explore innovative development models of industrial chains, build competitive advantages of the entire industrial chain of traditional Chinese medicine, improve operational quality and efficiency, and achieve steady improvement in operating performance and core capabilities. During the "14th Five-Year Plan" strategic period, China Resources Sanjiu made solid progress on the road to becoming a leading enterprise in the industry, benchmarking against world-class enterprises, improving business layout, expanding its core business into the entire field of self-diagnosis and treatment, developing business focus on pipelines, and as the core Business empowerment to form a business model with "deep roots and lush leaves". Looking to the future, China Resources Sanjiu will always keep in mind its original mission and work hard to work hard. Under the mission of "caring for public health and creating a better life together", we will forge ahead to the goal of "leader of the mass medical and health industry" and serve Every member of the Chinese family.
Jilin Wantong Group Co., Ltd.
After years of development, Jilin Wantong Group has become a large modern industrial group integrating pharmaceutical production, research and development and sales. After years of development, it now has three major industries. The first sector is the pharmaceutical industry, with Tonghua Wantong Pharmaceutical Co., Ltd. as its parent company. Its wholly-owned or controlled subsidiaries include Meihe Wantong Pharmaceutical, Jilin Wantong Pharmaceutical, and Zhengzhou Wantong Fusheng Pharmaceutical. Pharmaceutical companies, 2 participating planting companies, and 1 pharmaceutical distribution company in Wantong Pharmaceutical Distribution Company, etc.; the second sector is a diversified industry, with Wantong Wine Co., Ltd., Wantong Shengtai Bioengineering Company, Qingshui Liren Cosmetics Company, etc. The third sector is the energy industry, with 11 mining enterprises under Wanbang Mining Group. The group's headquarters is located in Tonghua City, Jilin Province. The group takes the pharmaceutical industry as the leading industry, and each industry promotes each other and develops in a coordinated manner. The group was founded on November 18, 1997. It was formerly the second state-owned pharmaceutical factory in Tonghua City. The company has been successively certified as a national key high-tech enterprise, a national torch plan key project enterprise, a national enterprise technology center, and an outstanding private technology enterprise in China. , National contract-abiding and credit-oriented enterprises, National model labor relations enterprises, "AAA"-level credit enterprises of Agricultural Bank of China, and national key leading enterprises in agricultural industrialization. It has won more than 100 awards including national advanced grassroots party organizations, national model workers' homes, national civilized units, national youth civilization numbers, national advanced private enterprises in employment and social security, Jilin Province model collectives, provincial and municipal taxpayer top prizes, etc.
Jilin Wantong Group Co., Ltd.
After years of development, Jilin Wantong Group has become a large modern industrial group integrating pharmaceutical production, research and development and sales. After years of development, it now has three major industries. The first sector is the pharmaceutical industry, with Tonghua Wantong Pharmaceutical Co., Ltd. as its parent company. Its wholly-owned or controlled subsidiaries include Meihe Wantong Pharmaceutical, Jilin Wantong Pharmaceutical, and Zhengzhou Wantong Fusheng Pharmaceutical. Pharmaceutical companies, 2 participating planting companies, and 1 pharmaceutical distribution company in Wantong Pharmaceutical Distribution Company, etc.; the second sector is a diversified industry, with Wantong Wine Co., Ltd., Wantong Shengtai Bioengineering Company, Qingshui Liren Cosmetics Company, etc. The third sector is the energy industry, with 11 mining enterprises under Wanbang Mining Group. The group's headquarters is located in Tonghua City, Jilin Province. The group takes the pharmaceutical industry as the leading industry, and each industry promotes each other and develops in a coordinated manner. The group was founded on November 18, 1997. It was formerly the second state-owned pharmaceutical factory in Tonghua City. The company has been successively certified as a national key high-tech enterprise, a national torch plan key project enterprise, a national enterprise technology center, and an outstanding private technology enterprise in China. , National contract-abiding and credit-oriented enterprises, National model labor relations enterprises, "AAA"-level credit enterprises of Agricultural Bank of China, and national key leading enterprises in agricultural industrialization. It has won more than 100 awards including national advanced grassroots party organizations, national model workers' homes, national civilized units, national youth civilization numbers, national advanced private enterprises in employment and social security, Jilin Province model collectives, provincial and municipal taxpayer top prizes, etc.
Teiyi Pharmaceutical Group Co., Ltd.
Teyi Pharmaceutical Group Co., Ltd. (hereinafter referred to as Teyi Pharmaceutical) is a pharmaceutical listed company (stock code 002728) integrating pharmaceutical research and development, pharmaceutical industry, and pharmaceutical commerce. Its subordinate enterprises are distributed in Guangdong, Hainan, Anhui and other regions. Teyi Pharmaceutical and its wholly-owned subsidiary Hainan Haili Pharmaceutical Co., Ltd. and Taishan Xinning Pharmaceutical Co., Ltd. are both national high-tech enterprises. Teyi Pharmaceutical has been successively rated as "Outstanding Contributor Enterprise in the Pharmaceutical Industry in Guangdong Province", "Netherlands Science and Technology Enterprise in Guangdong Province", "Netherlands Innovation Industrialization Demonstration Base", "Netherlands Innovation Enterprise in Guangdong Province", and "Abide by Contracts and Harmony Credit enterprises", "A-level taxpayer", "AA-level credit-grade customer", etc.; Hainan Haili Pharmaceutical Co., Ltd., a wholly-owned subsidiary of Teyi Pharmaceutical, has been successively rated as "National Intellectual Property Advantage Enterprise in 2018" and "Hainan Leading enterprises in the industrial industry (Chinese patent medicine manufacturing industry)", "national quality, service, and reputation AAA enterprises" and "A-level taxpayers", etc. Teyi Pharmaceutical industry includes Taishan pharmaceutical production base (formerly Guangdong Taicheng Pharmaceutical), Haikou pharmaceutical production base (Hainan Haili Pharmaceutical Co., Ltd.), raw material pharmaceutical production base (Taishan Xinning Pharmaceutical Co., Ltd.) and chemical product production base (Taishan Chemical Factory Co., Ltd.). Teyi Pharmaceutical Group's products include Chinese patent medicines, chemical preparations, chemical raw materials and chemical products. Among them, the "Special One" brand series covers cough and phlegm relief, kidney nourishment, anti-infection, cardiovascular and cerebrovascular and digestive system medications, among which the main preparation products include cough and anti-inflammatory tablets, Pudilan anti-inflammatory tablets, Xuesaitong dispersed tablets, Yixinshu Granules, Ginkgo Leaf Dispersion Tablets, Jinkui Shen Qi Tablets, Magnesium Aluminum Carbonate Chewable Tablets, Erythromycin Enteric Coated Tablets, Erythromycin Tablets, Rorythromycin Capsules, Amoxicillin Capsules, Omeprazole Enteric-coated capsules, etc.; the main chemical raw materials and chemical products include magnesium aluminum carbonate, sodium phenytoin, ferrous sulfate, glacial acetic acid, calcium chloride, sodium chloride, bismuth series, citric acid series, zinc sulfate, etc. Teyi Pharmaceutical's core product is cough-relieving tablets. Its secret recipe was included in the Lingnan Traditional Chinese Medicine Cultural Heritage Protection List (the first batch) in 2009 and was recognized as a key new product in Guangdong Province in 2012; a wholly-owned subsidiary Taishan Xinning Pharmaceutical The key products produced by the Co., Ltd. are magnesium aluminum carbonate, sodium phenytoin, glacial acetic acid, calcium chloride and other raw materials, and are ranked among the top in the national market share. Sodium chloride for injection and bismuth nitrate for basic use have been awarded the "National Medical Administration's high-quality product". In 2018, Teyi Pharmaceutical added pills and eye drops through asset acquisition. The main varieties of pills include Xuedu Pills, Xiaozhu Pills, Tongmai Zhanzhi Pills, Ruyi Dingpan Pills, Wulin Pills, Anti-Tube Pills, Menstrual Freckle Pills, etc. The main products of eye drops include compound dextran 70 eye drops wait. At the same time, the original product combination has also been enriched, such as the respiratory system, including Pudilan anti-inflammatory tablets, Hanhuangling Granules, Xiqingguo Granules, etc., the digestive system, Fengliao Intestine Weakang Tablets, etc., and Zhuangyao Jianshen Pills in Buyi. , Bushen Banlong Capsules, etc. have improved the segmentation of the product line for Teyi Pharmaceutical and also provided guarantees for the segmentation and refined promotion of sales channels. Teyi Pharmaceutical Group currently has two nationwide sales and commercial platforms, among which Guangdong Teyi Haili Pharmaceutical Co., Ltd. operates the "Teyi" brand series produced by Teyi Pharmaceutical Industry. Another commercial platform is Hainan Haili Doctor Pharmaceutical Group Co., Ltd., which operates OEM products of the "Haili Doctor" brand and adopts regional agency sales across the country, including Chinese patent medicines and chemical preparations, and is also diversified by Teyi Pharmaceutical. , an important support for the development of professional value-added business direction. In the future, Teyi Pharmaceutical will continue to adhere to the corporate purpose of "focusing on quality, strengthening R&D, and sustainable development", with endogenous growth as the core and external growth as the auxiliary, strengthen resource integration and internal potential tapping, and strive to build excellent brands and maintain the enterprise. and become a competitive pharmaceutical company.
Teiyi Pharmaceutical Group Co., Ltd.
Teyi Pharmaceutical Group Co., Ltd. (hereinafter referred to as Teyi Pharmaceutical) is a pharmaceutical listed company (stock code 002728) integrating pharmaceutical research and development, pharmaceutical industry, and pharmaceutical commerce. Its subordinate enterprises are distributed in Guangdong, Hainan, Anhui and other regions. Teyi Pharmaceutical and its wholly-owned subsidiary Hainan Haili Pharmaceutical Co., Ltd. and Taishan Xinning Pharmaceutical Co., Ltd. are both national high-tech enterprises. Teyi Pharmaceutical has been successively rated as "Outstanding Contributor Enterprise in the Pharmaceutical Industry in Guangdong Province", "Netherlands Science and Technology Enterprise in Guangdong Province", "Netherlands Innovation Industrialization Demonstration Base", "Netherlands Innovation Enterprise in Guangdong Province", and "Abide by Contracts and Harmony Credit enterprises", "A-level taxpayer", "AA-level credit-grade customer", etc.; Hainan Haili Pharmaceutical Co., Ltd., a wholly-owned subsidiary of Teyi Pharmaceutical, has been successively rated as "National Intellectual Property Advantage Enterprise in 2018" and "Hainan Leading enterprises in the industrial industry (Chinese patent medicine manufacturing industry)", "national quality, service, and reputation AAA enterprises" and "A-level taxpayers", etc. Teyi Pharmaceutical industry includes Taishan pharmaceutical production base (formerly Guangdong Taicheng Pharmaceutical), Haikou pharmaceutical production base (Hainan Haili Pharmaceutical Co., Ltd.), raw material pharmaceutical production base (Taishan Xinning Pharmaceutical Co., Ltd.) and chemical product production base (Taishan Chemical Factory Co., Ltd.). Teyi Pharmaceutical Group's products include Chinese patent medicines, chemical preparations, chemical raw materials and chemical products. Among them, the "Special One" brand series covers cough and phlegm relief, kidney nourishment, anti-infection, cardiovascular and cerebrovascular and digestive system medications, among which the main preparation products include cough and anti-inflammatory tablets, Pudilan anti-inflammatory tablets, Xuesaitong dispersed tablets, Yixinshu Granules, Ginkgo Leaf Dispersion Tablets, Jinkui Shen Qi Tablets, Magnesium Aluminum Carbonate Chewable Tablets, Erythromycin Enteric Coated Tablets, Erythromycin Tablets, Rorythromycin Capsules, Amoxicillin Capsules, Omeprazole Enteric-coated capsules, etc.; the main chemical raw materials and chemical products include magnesium aluminum carbonate, sodium phenytoin, ferrous sulfate, glacial acetic acid, calcium chloride, sodium chloride, bismuth series, citric acid series, zinc sulfate, etc. Teyi Pharmaceutical's core product is cough-relieving tablets. Its secret recipe was included in the Lingnan Traditional Chinese Medicine Cultural Heritage Protection List (the first batch) in 2009 and was recognized as a key new product in Guangdong Province in 2012; a wholly-owned subsidiary Taishan Xinning Pharmaceutical The key products produced by the Co., Ltd. are magnesium aluminum carbonate, sodium phenytoin, glacial acetic acid, calcium chloride and other raw materials, and are ranked among the top in the national market share. Sodium chloride for injection and bismuth nitrate for basic use have been awarded the "National Medical Administration's high-quality product". In 2018, Teyi Pharmaceutical added pills and eye drops through asset acquisition. The main varieties of pills include Xuedu Pills, Xiaozhu Pills, Tongmai Zhanzhi Pills, Ruyi Dingpan Pills, Wulin Pills, Anti-Tube Pills, Menstrual Freckle Pills, etc. The main products of eye drops include compound dextran 70 eye drops wait. At the same time, the original product combination has also been enriched, such as the respiratory system, including Pudilan anti-inflammatory tablets, Hanhuangling Granules, Xiqingguo Granules, etc., the digestive system, Fengliao Intestine Weakang Tablets, etc., and Zhuangyao Jianshen Pills in Buyi. , Bushen Banlong Capsules, etc. have improved the segmentation of the product line for Teyi Pharmaceutical and also provided guarantees for the segmentation and refined promotion of sales channels. Teyi Pharmaceutical Group currently has two nationwide sales and commercial platforms, among which Guangdong Teyi Haili Pharmaceutical Co., Ltd. operates the "Teyi" brand series produced by Teyi Pharmaceutical Industry. Another commercial platform is Hainan Haili Doctor Pharmaceutical Group Co., Ltd., which operates OEM products of the "Haili Doctor" brand and adopts regional agency sales across the country, including Chinese patent medicines and chemical preparations, and is also diversified by Teyi Pharmaceutical. , an important support for the development of professional value-added business direction. In the future, Teyi Pharmaceutical will continue to adhere to the corporate purpose of "focusing on quality, strengthening R&D, and sustainable development", with endogenous growth as the core and external growth as the auxiliary, strengthen resource integration and internal potential tapping, and strive to build excellent brands and maintain the enterprise. and become a competitive pharmaceutical company.
Jilin Wutai Gankang Pharmaceutical Co., Ltd.
Jilin Wutai Pharmaceutical Group Co., Ltd. is a well-known pharmaceutical enterprise group in China. Since the 1980s, it has entered the business world, pioneering and enterprising, and operates honestly, and has gradually developed into a combination of pharmaceutical production, scientific research and development, wholesale and retail, real estate development, healthy food production and development. A powerful enterprise group that integrates diversified operations across industries. Boy Excellence: The group owns many wholly-owned subsidiaries including Jilin Wutaigankang Pharmaceutical Co., Ltd., Jilin Wutaigankang Pharmaceutical Co., Ltd., and Jilin Northern Pharmaceutical Co., Ltd. The company's sales network covers more than 100 large and medium-sized cities across the country. So far, Gankang® product sales cover nearly 520,000 retail pharmacies, community service stations, etc., and the product sales have hit new highs in a row. The company now has more than 2,000 employees, including more than 50 senior management personnel and more than 80 senior scientific researchers. It has played its talents under the employment mechanism of the company's "goodness is like water, follow the trend, people-oriented, and burst out potential" to develop with the company. The group has adhered to the corporate spirit of "loyalty, tenacity, diligence and persistence" for many years, focused on the production and research and development of drugs, upholding a rigorous craftsmanship style, and is committed to becoming a leading enterprise in the field of medicine and health in my country. Keep improving and moving forward: The group currently has two pharmaceutical production bases, and its strong production capacity has laid a solid foundation for the development of the group and the production of medicines. "Gankang" production base - Jilin Wutai Gankang Pharmaceutical Co., Ltd. is located in Changchun Economic and Technological Development Zone. It was established in September 1999 with a total investment of RMB 120 million and covers an area of more than 60,000 square meters. The construction area is about 16,000 square meters, and it has many internationally advanced production lines, with an annual production capacity (single shift) of 1 billion tablets and 300 million capsules. In 2002, it was the first to pass the national GMP pharmaceutical manufacturer certification at one time. Since 2008, it has been recognized as a "high-tech enterprise" for many consecutive times. "Wu Tai" pharyngitis tablet production base - Jilin Wu Tai Gankang Pharmaceutical Co., Ltd. is located on the beautiful Songhua River. It completed the relocation of the old site and the construction of the factory in the end of 2003. The total investment is RMB 80 million and covers an area of RMB 100 million. More than 50,000 square meters, and passed the national GMP certification in 2004 and the new version of GMP certification in 2014. It now has 12 production lines including tablets, capsules, ointments, oral liquids, granules, and Chinese patent medicines, with more than 50 varieties. It is a pharmaceutical production base with international advanced production levels. In 2020, Wutai Pharmaceutical Industrial Park located in Xinglongshan Free Trade Zone in Changchun was officially opened. Phase I of the Industrial Park covers an area of about 100,000 square meters, with a total construction area of 750,000 square meters. 100 million yuan is invested to introduce advanced equipment and realize dedicated line production; it now has a modern comprehensive preparation workshop, a dedicated energy power center, and a smart logistics warehouse Six functional centers, including the center, sewage treatment station, comprehensive quality inspection office building, and leisure service center, are committed to building a first-class domestic pharmaceutical industry complex. The second phase of Wutai Pharmaceutical Industrial Park, with a planned building area of 150,000 square meters, mainly focusing on traditional Chinese medicine production, including preparation building, R&D center, traditional Chinese medicine extraction workshop, pilot workshop, office building and related supporting facilities. It has the most production capacity in Jilin Province. Large traditional Chinese medicine production workshop. After reaching full capacity, the annual total output value is expected to be 3 billion yuan, and the annual profit and tax can reach 500 million yuan. After all the first and second phases of the project are put into production, the annual total output value can reach 5 billion yuan and the total profit and tax will reach 1 billion yuan, which will become a modern pharmaceutical production base with international standards.
Jilin Wutai Gankang Pharmaceutical Co., Ltd.
Jilin Wutai Pharmaceutical Group Co., Ltd. is a well-known pharmaceutical enterprise group in China. Since the 1980s, it has entered the business world, pioneering and enterprising, and operates honestly, and has gradually developed into a combination of pharmaceutical production, scientific research and development, wholesale and retail, real estate development, healthy food production and development. A powerful enterprise group that integrates diversified operations across industries. Boy Excellence: The group owns many wholly-owned subsidiaries including Jilin Wutaigankang Pharmaceutical Co., Ltd., Jilin Wutaigankang Pharmaceutical Co., Ltd., and Jilin Northern Pharmaceutical Co., Ltd. The company's sales network covers more than 100 large and medium-sized cities across the country. So far, Gankang® product sales cover nearly 520,000 retail pharmacies, community service stations, etc., and the product sales have hit new highs in a row. The company now has more than 2,000 employees, including more than 50 senior management personnel and more than 80 senior scientific researchers. It has played its talents under the employment mechanism of the company's "goodness is like water, follow the trend, people-oriented, and burst out potential" to develop with the company. The group has adhered to the corporate spirit of "loyalty, tenacity, diligence and persistence" for many years, focused on the production and research and development of drugs, upholding a rigorous craftsmanship style, and is committed to becoming a leading enterprise in the field of medicine and health in my country. Keep improving and moving forward: The group currently has two pharmaceutical production bases, and its strong production capacity has laid a solid foundation for the development of the group and the production of medicines. "Gankang" production base - Jilin Wutai Gankang Pharmaceutical Co., Ltd. is located in Changchun Economic and Technological Development Zone. It was established in September 1999 with a total investment of RMB 120 million and covers an area of more than 60,000 square meters. The construction area is about 16,000 square meters, and it has many internationally advanced production lines, with an annual production capacity (single shift) of 1 billion tablets and 300 million capsules. In 2002, it was the first to pass the national GMP pharmaceutical manufacturer certification at one time. Since 2008, it has been recognized as a "high-tech enterprise" for many consecutive times. "Wu Tai" pharyngitis tablet production base - Jilin Wu Tai Gankang Pharmaceutical Co., Ltd. is located on the beautiful Songhua River. It completed the relocation of the old site and the construction of the factory in the end of 2003. The total investment is RMB 80 million and covers an area of RMB 100 million. More than 50,000 square meters, and passed the national GMP certification in 2004 and the new version of GMP certification in 2014. It now has 12 production lines including tablets, capsules, ointments, oral liquids, granules, and Chinese patent medicines, with more than 50 varieties. It is a pharmaceutical production base with international advanced production levels. In 2020, Wutai Pharmaceutical Industrial Park located in Xinglongshan Free Trade Zone in Changchun was officially opened. Phase I of the Industrial Park covers an area of about 100,000 square meters, with a total construction area of 750,000 square meters. 100 million yuan is invested to introduce advanced equipment and realize dedicated line production; it now has a modern comprehensive preparation workshop, a dedicated energy power center, and a smart logistics warehouse Six functional centers, including the center, sewage treatment station, comprehensive quality inspection office building, and leisure service center, are committed to building a first-class domestic pharmaceutical industry complex. The second phase of Wutai Pharmaceutical Industrial Park, with a planned building area of 150,000 square meters, mainly focusing on traditional Chinese medicine production, including preparation building, R&D center, traditional Chinese medicine extraction workshop, pilot workshop, office building and related supporting facilities. It has the most production capacity in Jilin Province. Large traditional Chinese medicine production workshop. After reaching full capacity, the annual total output value is expected to be 3 billion yuan, and the annual profit and tax can reach 500 million yuan. After all the first and second phases of the project are put into production, the annual total output value can reach 5 billion yuan and the total profit and tax will reach 1 billion yuan, which will become a modern pharmaceutical production base with international standards.
Chenxin Pharmaceutical Jilin Co., Ltd.
Chenxin Pharmaceutical Jilin Co., Ltd. was established in the early 1970s and began to produce and sell donkey-hide gelatin in the market in 1975. In 2013, Shuangyao Group and Shandong Chenxin Technology Group Co., Ltd. joined forces to enter the fast lane of enterprise development. In the same year, it has a pre-processing and extraction workshop, a fermentation workshop and two oral solid preparation workshops that have passed the GMP certification. It can produce 1 billion tablets, 1 billion capsules, 200 million bags of granules, 200 million pills, and 30 tons of water pills. After several years of entrepreneurship, Chenxin Pharmaceutical Jilin Co., Ltd. has developed into a major production and sales of Chinese and Western medicine preparations. The company has 48 varieties of national medicine-accurate drugs, including donkey-hide gelatin, Jinkexi Capsules and other flagship products; There are also patents that use modern biotechnology to ferment in depth.
Chenxin Pharmaceutical Jilin Co., Ltd.
Chenxin Pharmaceutical Jilin Co., Ltd. was established in the early 1970s and began to produce and sell donkey-hide gelatin in the market in 1975. In 2013, Shuangyao Group and Shandong Chenxin Technology Group Co., Ltd. joined forces to enter the fast lane of enterprise development. In the same year, it has a pre-processing and extraction workshop, a fermentation workshop and two oral solid preparation workshops that have passed the GMP certification. It can produce 1 billion tablets, 1 billion capsules, 200 million bags of granules, 200 million pills, and 30 tons of water pills. After several years of entrepreneurship, Chenxin Pharmaceutical Jilin Co., Ltd. has developed into a major production and sales of Chinese and Western medicine preparations. The company has 48 varieties of national medicine-accurate drugs, including donkey-hide gelatin, Jinkexi Capsules and other flagship products; There are also patents that use modern biotechnology to ferment in depth.
Suicheng Pharmaceutical Co., Ltd.
Suicheng Pharmaceutical Co., Ltd. is a modern high-tech enterprise that uses modern biotechnology and integrates drug research and development, production, sales and vocational education. The company currently has 1,653 employees and assets of more than 900 million yuan. The main products include 19 dosage forms such as water injection, tablets, capsules, granules, and pastes, and more than 180 varieties. It is equipped with medicinal ampoules, packaging, printing, The irradiation industry chain, all production workshops have passed the national GMP certification. The company's products are sold well all over the country, and 36 varieties are sold abroad. The company's annual production capacity of water injections can reach 2 billion units, ranking among the top in the country, and its economic efficiency indicators rank among the top in the country. It is a backbone enterprise of the pharmaceutical industry in the province and city, a multi-variety preparation export enterprise in Henan Province, and a vanguard of the pharmaceutical industry in Zhengzhou. The company has the "Provincial Enterprise Technology Center", the "Henan Province Innovation Drug Preparation Engineering Research Center" and the "Zhengzhou Green Synthesis Academician Workstation". It has undertaken more than 30 major national, provincial and municipal scientific and technological projects, participated in the formulation of 24 national medical standards, owned 256 patents of various types, held 21 national new drug certificates, undertaken 3 national torch plan projects, and 58 products were selected. "National Catalogue of Essential Medicines". In the past three years, the company has invested more than 300 million yuan in new drug research and development and drug consistency evaluation, and 3-5 new products are put on the market every year. The R&D team was rated as a provincial "Innovative Technology Team". In the next step, the company will continue to increase investment in scientific and technological research and development, adhere to innovation-driven development, focus on brand building, and take injections, urgently grab drugs, and specialized drugs as the leader, accelerate new drug research and development and drug consistency evaluation, continuously improve market competitiveness, and promote enterprises. Be better and stronger.
Suicheng Pharmaceutical Co., Ltd.
Suicheng Pharmaceutical Co., Ltd. is a modern high-tech enterprise that uses modern biotechnology and integrates drug research and development, production, sales and vocational education. The company currently has 1,653 employees and assets of more than 900 million yuan. The main products include 19 dosage forms such as water injection, tablets, capsules, granules, and pastes, and more than 180 varieties. It is equipped with medicinal ampoules, packaging, printing, The irradiation industry chain, all production workshops have passed the national GMP certification. The company's products are sold well all over the country, and 36 varieties are sold abroad. The company's annual production capacity of water injections can reach 2 billion units, ranking among the top in the country, and its economic efficiency indicators rank among the top in the country. It is a backbone enterprise of the pharmaceutical industry in the province and city, a multi-variety preparation export enterprise in Henan Province, and a vanguard of the pharmaceutical industry in Zhengzhou. The company has the "Provincial Enterprise Technology Center", the "Henan Province Innovation Drug Preparation Engineering Research Center" and the "Zhengzhou Green Synthesis Academician Workstation". It has undertaken more than 30 major national, provincial and municipal scientific and technological projects, participated in the formulation of 24 national medical standards, owned 256 patents of various types, held 21 national new drug certificates, undertaken 3 national torch plan projects, and 58 products were selected. "National Catalogue of Essential Medicines". In the past three years, the company has invested more than 300 million yuan in new drug research and development and drug consistency evaluation, and 3-5 new products are put on the market every year. The R&D team was rated as a provincial "Innovative Technology Team". In the next step, the company will continue to increase investment in scientific and technological research and development, adhere to innovation-driven development, focus on brand building, and take injections, urgently grab drugs, and specialized drugs as the leader, accelerate new drug research and development and drug consistency evaluation, continuously improve market competitiveness, and promote enterprises. Be better and stronger.
Jilin Jill Pharmaceutical Co., Ltd.
Jilin Jierji Pharmaceutical Co., Ltd. is located in the beautiful Jiangcheng Jilin City. It is a comprehensive pharmaceutical enterprise integrating R&D, production and sales. The company was founded in 2000 and has 76 product approval numbers and 5 patented varieties. In 2017, the company moved as a whole to the "Girji Pharmaceutical and Health Industry Park" located in Jilin High-tech North District. In June 2018, it passed the drug GMP certification and started production. The project covers an area of 287,000 square meters, with a total construction area of about 200,000 square meters, and a total investment of about 1.2 billion yuan. The products cover the endocrine system, cardiovascular and cerebrovascular system, respiratory system, digestive system, gynecology, rheumatoid arthritis, tumors and anti-infection fields. At present, a product group with traditional Chinese medicine as the main one and both Chinese and Western medicines has been formed. The annual production capacity can reach 20 billion tablets, 20 billion capsules, 10 billion pills of pills, 200 million bags of granules, 1 billion bottles of oral liquid, 20 million bottles of sprays, 20 million decoction creams, 10 million glues 120 million patches, 3000 tons of formula granules. Girji Pharmaceutical takes the "health, energy conservation, environmental protection, green and high-tech" big health industry as its development concept, adheres to planning and construction with high starting point and high-level standards, and takes modern Chinese medicine and health products as the main body of production. We will strive to create a big health industry, go global, and achieve the strategic goal of "gathering global technology and building a pharmaceutical aircraft carrier".
Jilin Jill Pharmaceutical Co., Ltd.
Jilin Jierji Pharmaceutical Co., Ltd. is located in the beautiful Jiangcheng Jilin City. It is a comprehensive pharmaceutical enterprise integrating R&D, production and sales. The company was founded in 2000 and has 76 product approval numbers and 5 patented varieties. In 2017, the company moved as a whole to the "Girji Pharmaceutical and Health Industry Park" located in Jilin High-tech North District. In June 2018, it passed the drug GMP certification and started production. The project covers an area of 287,000 square meters, with a total construction area of about 200,000 square meters, and a total investment of about 1.2 billion yuan. The products cover the endocrine system, cardiovascular and cerebrovascular system, respiratory system, digestive system, gynecology, rheumatoid arthritis, tumors and anti-infection fields. At present, a product group with traditional Chinese medicine as the main one and both Chinese and Western medicines has been formed. The annual production capacity can reach 20 billion tablets, 20 billion capsules, 10 billion pills of pills, 200 million bags of granules, 1 billion bottles of oral liquid, 20 million bottles of sprays, 20 million decoction creams, 10 million glues 120 million patches, 3000 tons of formula granules. Girji Pharmaceutical takes the "health, energy conservation, environmental protection, green and high-tech" big health industry as its development concept, adheres to planning and construction with high starting point and high-level standards, and takes modern Chinese medicine and health products as the main body of production. We will strive to create a big health industry, go global, and achieve the strategic goal of "gathering global technology and building a pharmaceutical aircraft carrier".
Prestige Consumer Healthcare
Luden's is known for its classic throat lozenges that offer soothing relief for sore throats and coughs.
Prestige Consumer Healthcare
Luden's is known for its classic throat lozenges that offer soothing relief for sore throats and coughs.
Cepacol is a trusted brand for throat sprays and lozenges, known for its effectiveness in soothing sore throats and reducing irritation.
Reckitt Benckiser
Cepacol is a trusted brand for throat sprays and lozenges, known for its effectiveness in soothing sore throats and reducing irritation.
Prestige Consumer Healthcare
Chloraseptic is a well-known brand offering throat sprays that provide fast relief from sore throat pain with active ingredients like phenol.
Prestige Consumer Healthcare
Chloraseptic is a well-known brand offering throat sprays that provide fast relief from sore throat pain with active ingredients like phenol.
Strepsils offers soothing lozenges for sore throats and coughs, providing quick and effective relief.
Reckitt Benckiser
Strepsils offers soothing lozenges for sore throats and coughs, providing quick and effective relief.
Nin Jiom Medicine Manufactory (H.K.) Ltd
Nin Jiom is famous for its herbal remedies, particularly its autumn pear syrup, which is widely used for soothing throats.
Nin Jiom Medicine Manufactory (H.K.) Ltd
Nin Jiom is famous for its herbal remedies, particularly its autumn pear syrup, which is widely used for soothing throats.
Guangzhou Witch Hazel Trading Co., Ltd.
The Secret of a Centennial Formula 10 Years Younger Thayers is an American natural organic brand founded in 1847. It is famous in the United States for its toner and moisturizing spray. Especially for toner, many manufacturers keep imitating his formula, but no one has surpassed his quality for a hundred years. The secret is that it uses the top organically grown aloe vera in the United States, plus the unique witch hazel extract essence in North America, and forges unique to the exclusive formula! Thayers rarely advertises, and rely on the good reputation of customers to pass on word of mouth, creating a century-old brand with a high return rate. In 2004, after Thayers' products were introduced to China, they were quickly welcomed and popular among Chinese consumers. The reason is that these 9 waters are not only suitable for men, women, age and age, but also suitable for any skin (including sensitive skin). In just a few years, with outstanding quality and affordable prices, it has successfully won a large number of loyal users of Witch Hazel. This magical magic water has become a must-have choice for many women's daily skin care. A century of classics lead the future In 1847, on Main Street, Cambridge, Massachusetts, USA, Dr. Henry Thayer M.D founded a laboratory that used innovative preparation methods to extract herbal essences and make semi-finished products, which were supplied and sold to the medical community. Henry was born in a Massachusetts family in 1828 and his father was a doctor. Every day, Henry received his father's training in medical skills. The new formulation method he created at that time was a historic first in the American pharmaceutical industry. This new method standardizes the concentration of the drug and helps doctors better grasp the accuracy of dose adjustment. The company is named Henry Thayer&Company. The company continued to expand its product range and flourished, becoming the largest pharmaceutical manufacturer during the American Civil War. In 1875, Thayers published the "Catalogue of Vacuum Extraction of Liquid and Solid Essences", which listed more than 800 product categories: based on herbs, and the finished products include tincture herbs, injections, syrups, ointments and medicinal wine. The most important product is the high-quality witch hazel extract native to North America, which is known as "a good medicine for beautification, anti-inflammatory and sedation, and has unique therapeutic effects on skin astringency and ejaculation control." The book finally points out that the herbal ingredients are also widely used in related prescription drugs, including sugar-coated tablets, patient diet adjustments, and countless synthetic drugs for treating coughs. Thayers's original herbal ingredients are known as "the beauty product of skin for sudden problems", "hair conditioning nutrients", and "natural lemon cooling powder without industrial processing". After Dr. Henry Thayer M.D died in 1902, his eldest niece, Madame Joseph Sturdevant, inherited his career. Afterwards, the company began to expand the business model of specialized pharmacies to manufacture and sell formulas and drugs, including children's medicine series, with a total of nine varieties, with the product names containing the words "Tots" (children); there are ointments, cough medicines and elm. Ye Runhu cough relief pills, etc. In 1947, a partnership composed of former roommates and retired sailors from Harvard University in the United States, Chase and Storrow, Boston, purchased Thayers from Mrs. Joseph Sturdevant. In New England, the first time it began to expand its marketing and advertising strategies, and actively invested in various marketing and advertising strategies, expanding to the western Hudson River area. In the following decade, the United States and Canada established independent specialized pharmacies and natural product stores. While selling cough medicines, new products were also added, such as cough syrup, nasal drops, cold analgesic oil, and cough nemesis? . In 1989, Thayers decided to use Thayers' exclusive secret recipes from the ranks of healthy food and natural care products to add the "North American witch hazel with natural aloe" series of products. This unique and unique ancestral secret recipe product has outstanding effects of calming and controlling oil, cleaning and smoothing skin. In 1999, the company resold it to Karen Clarke. Before that, she had been the general manager of Thayers for five years and had rich experience in management and management. When Karen's son, John Gehr, joined the company as Vice President of Marketing and Sales in 2003, Thayers' family business tradition has been once again developed in the United States and even North America. Focusing on manufacturing natural health medicines and beauty care products containing high quality and unique functions is the basic principle that Thayers has adhered to for more than a hundred years, and it is this consistent principle that ensures that Thayers has been prosperous for a long time. The company owners are full of confidence and perseverance. Together, they will surely be more prosperous and passed down from generation to generation in the 21st century.
Guangzhou Witch Hazel Trading Co., Ltd.
The Secret of a Centennial Formula 10 Years Younger Thayers is an American natural organic brand founded in 1847. It is famous in the United States for its toner and moisturizing spray. Especially for toner, many manufacturers keep imitating his formula, but no one has surpassed his quality for a hundred years. The secret is that it uses the top organically grown aloe vera in the United States, plus the unique witch hazel extract essence in North America, and forges unique to the exclusive formula! Thayers rarely advertises, and rely on the good reputation of customers to pass on word of mouth, creating a century-old brand with a high return rate. In 2004, after Thayers' products were introduced to China, they were quickly welcomed and popular among Chinese consumers. The reason is that these 9 waters are not only suitable for men, women, age and age, but also suitable for any skin (including sensitive skin). In just a few years, with outstanding quality and affordable prices, it has successfully won a large number of loyal users of Witch Hazel. This magical magic water has become a must-have choice for many women's daily skin care. A century of classics lead the future In 1847, on Main Street, Cambridge, Massachusetts, USA, Dr. Henry Thayer M.D founded a laboratory that used innovative preparation methods to extract herbal essences and make semi-finished products, which were supplied and sold to the medical community. Henry was born in a Massachusetts family in 1828 and his father was a doctor. Every day, Henry received his father's training in medical skills. The new formulation method he created at that time was a historic first in the American pharmaceutical industry. This new method standardizes the concentration of the drug and helps doctors better grasp the accuracy of dose adjustment. The company is named Henry Thayer&Company. The company continued to expand its product range and flourished, becoming the largest pharmaceutical manufacturer during the American Civil War. In 1875, Thayers published the "Catalogue of Vacuum Extraction of Liquid and Solid Essences", which listed more than 800 product categories: based on herbs, and the finished products include tincture herbs, injections, syrups, ointments and medicinal wine. The most important product is the high-quality witch hazel extract native to North America, which is known as "a good medicine for beautification, anti-inflammatory and sedation, and has unique therapeutic effects on skin astringency and ejaculation control." The book finally points out that the herbal ingredients are also widely used in related prescription drugs, including sugar-coated tablets, patient diet adjustments, and countless synthetic drugs for treating coughs. Thayers's original herbal ingredients are known as "the beauty product of skin for sudden problems", "hair conditioning nutrients", and "natural lemon cooling powder without industrial processing". After Dr. Henry Thayer M.D died in 1902, his eldest niece, Madame Joseph Sturdevant, inherited his career. Afterwards, the company began to expand the business model of specialized pharmacies to manufacture and sell formulas and drugs, including children's medicine series, with a total of nine varieties, with the product names containing the words "Tots" (children); there are ointments, cough medicines and elm. Ye Runhu cough relief pills, etc. In 1947, a partnership composed of former roommates and retired sailors from Harvard University in the United States, Chase and Storrow, Boston, purchased Thayers from Mrs. Joseph Sturdevant. In New England, the first time it began to expand its marketing and advertising strategies, and actively invested in various marketing and advertising strategies, expanding to the western Hudson River area. In the following decade, the United States and Canada established independent specialized pharmacies and natural product stores. While selling cough medicines, new products were also added, such as cough syrup, nasal drops, cold analgesic oil, and cough nemesis? . In 1989, Thayers decided to use Thayers' exclusive secret recipes from the ranks of healthy food and natural care products to add the "North American witch hazel with natural aloe" series of products. This unique and unique ancestral secret recipe product has outstanding effects of calming and controlling oil, cleaning and smoothing skin. In 1999, the company resold it to Karen Clarke. Before that, she had been the general manager of Thayers for five years and had rich experience in management and management. When Karen's son, John Gehr, joined the company as Vice President of Marketing and Sales in 2003, Thayers' family business tradition has been once again developed in the United States and even North America. Focusing on manufacturing natural health medicines and beauty care products containing high quality and unique functions is the basic principle that Thayers has adhered to for more than a hundred years, and it is this consistent principle that ensures that Thayers has been prosperous for a long time. The company owners are full of confidence and perseverance. Together, they will surely be more prosperous and passed down from generation to generation in the 21st century.
Siping Vickers Heat Exchange Equipment Co., Ltd.
China Siping Vickers Heat Exchange Equipment Co., Ltd. is a core member unit of Vickers International Group. It is currently one of the largest and most comprehensive professional manufacturing companies for heat exchange equipment in Asia. The design, manufacturing and R&D base of Vickers International Group is composed of branches with regional centers such as France, the United States, and Singapore, and its sales service network is spread all over the world. Integrating international advanced technology, Viex Group continues to innovate, and now ViEX has become a world-renowned manufacturer of heat exchange equipment. Over the past few decades, from Siping Heat Exchanger Factory to Siping Vickers Company, it has developed leap forward and bigger and stronger. The current garden-style factory covers an area of 60,000 square meters and has a construction area of 26,000 square meters. In 2004, after introducing the complete set of French fine molds and production processes, it has been continuously improved and optimized. Now we have 310 sets of various production, processing and inspection equipment. There are 460 fixed employees in the enterprise. Among them, scientific and technological personnel account for about 50% of the total number of employees. With the completion of the renovation of the old industrial base project in Northeast China, the company has expanded its production scale and capacity. Business scope Heat exchange equipment, environmental protection equipment and their edge products design, manufacturing, and sales; import and export of goods; import and export of technology and their agents. Corporate capabilities It produces 200,000 square meters and 4,000 sets (sets) of various heat exchange equipment annually. Annual sales of RMB 300 million, of which exports earn US$10 million.
Siping Vickers Heat Exchange Equipment Co., Ltd.
China Siping Vickers Heat Exchange Equipment Co., Ltd. is a core member unit of Vickers International Group. It is currently one of the largest and most comprehensive professional manufacturing companies for heat exchange equipment in Asia. The design, manufacturing and R&D base of Vickers International Group is composed of branches with regional centers such as France, the United States, and Singapore, and its sales service network is spread all over the world. Integrating international advanced technology, Viex Group continues to innovate, and now ViEX has become a world-renowned manufacturer of heat exchange equipment. Over the past few decades, from Siping Heat Exchanger Factory to Siping Vickers Company, it has developed leap forward and bigger and stronger. The current garden-style factory covers an area of 60,000 square meters and has a construction area of 26,000 square meters. In 2004, after introducing the complete set of French fine molds and production processes, it has been continuously improved and optimized. Now we have 310 sets of various production, processing and inspection equipment. There are 460 fixed employees in the enterprise. Among them, scientific and technological personnel account for about 50% of the total number of employees. With the completion of the renovation of the old industrial base project in Northeast China, the company has expanded its production scale and capacity. Business scope Heat exchange equipment, environmental protection equipment and their edge products design, manufacturing, and sales; import and export of goods; import and export of technology and their agents. Corporate capabilities It produces 200,000 square meters and 4,000 sets (sets) of various heat exchange equipment annually. Annual sales of RMB 300 million, of which exports earn US$10 million.
Fleetwood Loft House Limited (UK)
Fisherman's Friend is a powerful mint-throated candy developed by a pharmacist named James Lofthouse in 1865 to alleviate various breathing problems caused by fishermen's harsh environments in Iceland's fishing sites. Originally a potion containing mint and eucalyptus oil, Lofthouse made this liquid into throat candy to make it easier to transport and manage. Soon the fishermen began to liken this throat candy to their "friends", which is also the origin of its name. This throat lozenges can effectively relieve cough symptoms caused by colds. Today, the "Fisherman's Treasure" markets many countries around the world. The way of success lies in maintaining consistent good product quality, which makes people feel unspeakable and refreshing. It has been carried out in an attempt to make it in the international market. High status. Fisherman's Treasure Original Throat Lotion dates back to 1865. Fisherman's Treasure's Special Mint-flavored throat candy appeared in the early 1980s. As demand for sugar-free products continued to increase, the company launched sugar-free mint-flavored throat candy in 1991. 1997 was an important year because the company launched the fruit-flavored throat lozenges, Fisherman's Bonuses Specialty Throat Lozenges (lemon flavor - sugar-free). Since its launch in the Asian market, citrus grapefruit-flavored throat candy has become one of the popular flavors. Fisherman's Treasure is now available in a variety of flavors, some of which are only available in specific areas. The striped ones on the packaging are sugar-free.
Fleetwood Loft House Limited (UK)
Fisherman's Friend is a powerful mint-throated candy developed by a pharmacist named James Lofthouse in 1865 to alleviate various breathing problems caused by fishermen's harsh environments in Iceland's fishing sites. Originally a potion containing mint and eucalyptus oil, Lofthouse made this liquid into throat candy to make it easier to transport and manage. Soon the fishermen began to liken this throat candy to their "friends", which is also the origin of its name. This throat lozenges can effectively relieve cough symptoms caused by colds. Today, the "Fisherman's Treasure" markets many countries around the world. The way of success lies in maintaining consistent good product quality, which makes people feel unspeakable and refreshing. It has been carried out in an attempt to make it in the international market. High status. Fisherman's Treasure Original Throat Lotion dates back to 1865. Fisherman's Treasure's Special Mint-flavored throat candy appeared in the early 1980s. As demand for sugar-free products continued to increase, the company launched sugar-free mint-flavored throat candy in 1991. 1997 was an important year because the company launched the fruit-flavored throat lozenges, Fisherman's Bonuses Specialty Throat Lozenges (lemon flavor - sugar-free). Since its launch in the Asian market, citrus grapefruit-flavored throat candy has become one of the popular flavors. Fisherman's Treasure is now available in a variety of flavors, some of which are only available in specific areas. The striped ones on the packaging are sugar-free.
Ricola is a well-known manufacturer of throat and mints in Switzerland. The company was established in 1930, and its headquarters was established in the Swiss city of Lefen, emphasizing the natural herbal materials used during production. Swiss Liqueur Natural Vanilla Sugar, unique flavor and refreshing and moisturizing. In order to cater to different consumers' preferences, Liqueur is also available in original flavors, lemon and extra strong mint for choice. In the early 1980s, Hong Kong Liquor Mint Advertising invited the well-known Cantonese film The Gang Kao Shi Jian to perform, successfully creating the image of "the traitor has its own tricks" for the brand, which was deeply rooted in the hearts of the people. In order to maintain a clear voice, the well-known king Michael Jackson usually adds two drops of Ricola to a cup of hot water before drinking it.
DKSH Hong Kong Limited
Ricola is a well-known manufacturer of throat and mints in Switzerland. The company was established in 1930, and its headquarters was established in the Swiss city of Lefen, emphasizing the natural herbal materials used during production. Swiss Liqueur Natural Vanilla Sugar, unique flavor and refreshing and moisturizing. In order to cater to different consumers' preferences, Liqueur is also available in original flavors, lemon and extra strong mint for choice. In the early 1980s, Hong Kong Liquor Mint Advertising invited the well-known Cantonese film The Gang Kao Shi Jian to perform, successfully creating the image of "the traitor has its own tricks" for the brand, which was deeply rooted in the hearts of the people. In order to maintain a clear voice, the well-known king Michael Jackson usually adds two drops of Ricola to a cup of hot water before drinking it.
Dr. John's produces throat lozenges with natural ingredients like honey and lemon for soothing relief.
Dr. John's Products Ltd.
Dr. John's produces throat lozenges with natural ingredients like honey and lemon for soothing relief.
